Loading
HY
Hyloris Stock: price and insider trades · Belgium
No insider purchase over the last 90 days. The latest was filed 14 Jun 2023.
Hyloris: what insiders have been doing
Every trade that managers of Hyloris disclose to FSMA is tracked on this page. The company is based in Belgium. From 18 October 2025 to 18 October 2026, the disclosure feed for Hyloris logged 2 filings by 2 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Compared with its exchange (77 companies, median 10 filings), a count of 2 filings is below the norm. Our records for Hyloris go back to 2022, with 8 purchases and 3 sales on the open market in total.
There has been no open-market purchase by an insider of Hyloris for at least a year.
These figures are compiled from regulatory filings published by FSMA. They describe what insiders did and are not a recommendation.
Key facts
Headquarters: Belgium
Source: Wikidata (CC0).
Insider Decl.
15
Thresholds
n/a
Buy Volume
€4M
8 ops. · all time
Sell Volume
€184,483
3 ops. · all time
Since the insiders bought
- +0.4%Entry €11.65 · Close at T+365 €11.70
- +0.4%Entry €11.65 · Close at T+365 €11.70
- -3.3%Entry €12.10 · Close at T+365 €11.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Hyloris Buy (bullish), based on 3 analysts. Average price target: €11.23.
Fundamental score
Ranked 20,050 of 24,148 companies
28.4
score / 100
Value20
Quality37
FCF yld-6.7%
Earn yld-5.5%
EV/EBITDA·
ROE-17%
Gross mgn95%
Net mgn-88%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€4.08
Analyst consensus
3 analystsBuy
€6.00Target €11.23(+175%)€17.20
Income statement
Revenue€7.2M
Gross profit€6.8M95% margin
EBITDA-€5.9M-82% margin
Net income-€6.3M-47.4% margin
Valuation
PER (forward)-20.4x
P/Book4.4x
Beta0.64
Balance sheet & cash
Market cap€114.2M
Total debt€1.6M
Free Cash Flow-€7.6M
Debt / Equity6%
Profitability & ownership
ROE-17.3%
ROA-11.3%
% insiders56.6%
% institutions0.0%
Last declaration on 25 November 2025
Declarations15 total
425,000 shares0ShareEuronext BrusselsISIN BE0974363955FSMA:hyloris
425,000 shares0ShareEuronext BrusselsISIN BE0974363955FSMA:hyloris-0
12,500 shares@ €11.5529.4% of flowShareOff exchangeISIN BE0974363955FSMA:hyloris-13
Canonical exit: 11 Sept 2023 (T+90)
6,000 shares@ €11.5557.1% of flowShareOff exchangeISIN BE0974363955FSMA:hyloris-12
Canonical exit: 11 Sept 2023 (T+90)
33,333 shares@ €0.010.0% of flowShareOff exchangeISIN BE0974363955FSMA:hyloris-11
Canonical exit: 9 Aug 2023 (T+90)
66,667 shares@ €0.01100.0% of flowShareOff exchangeISIN BE0974363955FSMA:hyloris-10
Canonical exit: 9 Aug 2023 (T+90)
167,000 shares@ €12.8584.8% of flowShareOff exchangeISIN BE0974363955FSMA:hyloris-9
Canonical exit: 31 Jul 2023 (T+90)
80,000 shares@ €12.85100.0% of flowShareOff exchangeISIN BE0974363955FSMA:hyloris-8
Canonical exit: 31 Jul 2023 (T+90)
163,512 shares@ €2.3615.2% of flowShareEuronext BrusselsISIN BE0974363955FSMA:hyloris-7
852,096 shares@ €2.36100.0% of flowShareEuronext BrusselsISIN BE0974363955FSMA:hyloris-6
5,000 shares@ €17.2046.6% of flowShareEuronext BrusselsISIN BE0974363955FSMA:hyloris-5
3,312 shares@ €17.0530.6% of flowShareEuronext BrusselsISIN BE0974363955FSMA:hyloris-4
2,500 shares@ €16.8022.8% of flowShareEuronext BrusselsISIN BE0974363955FSMA:hyloris-3
20,000 shares@ €17.3570.6% of flowShareEuronext BrusselsISIN BE0974363955FSMA:hyloris-2
Canonical exit: 20 Jun 2022 (T+90)
3,000 shares@ €17.3542.9% of flowShareOff exchangeISIN BE0974363955FSMA:hyloris-1
Canonical exit: 20 Jun 2022 (T+90)
15 of 15 declarations
About Hyloris
Hyloris is a company listed on the XBRU market. It specializes in developing innovative solutions in the healthcare sector.
